| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |